Results 71 to 80 of about 7,597,013 (263)

Modeling of shear deficient beams by the mixed smeared/discrete cracking approach

open access: yesHBRC Journal, 2016
This paper presents an analytical study on the modeling of shear critical reinforced concrete beams modeled using the finite element method. The paper investigates two modeling strategies; the first of which is the well established smeared cracking ...
Dina Muhammad Fathi Ors   +2 more
doaj   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Types and frequency of laboratory errors in Sawanpracharak hospital, Nakornsawan province: One year after laboratory accreditation

open access: yesJournal of Associated Medical Sciences, 2010
Since  laboratory  tests  provide  essential  information  for  physicians  to  make  medical  decisions  for diagnosis, treatment and monitoring of the patient’s condition, we evaluated the types and frequency of errors in our  in-patient  department ...
Pakasit Pratoomtone
doaj  

Frequency of Pre-Analytical Errors and Its Causes in Glucose Specimen Collection: A Cross-Sectional Analysis in Bahawal Victoria Hospital, Pakistan

open access: yesPakistan Journal of Medicine and Dentistry
Background: The laboratory testing process comprises the pre-analytical, analytical, and post-analytical phases. The pre-analytical phase has the highest frequency of error among these three stages.
Hafiza Asma Hafiz   +5 more
doaj   +1 more source

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

open access: yesMolecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou   +4 more
wiley   +1 more source

PENGARUH PENERAPAN MODEL PEMBELAJARAN GROUP INVESTIGATION (GI) TERHADAP KEMAMPUAN BERPIKIR ANALISIS SISWA PADA MATERI PENCEMARAN LINGKUNGAN

open access: yesBiosfer, 2018
The analytical thinking skill is a part of the higher order thinking process. The analytical thinking skill is needed to solve a problem in learning process.
Ade Suryanda   +2 more
doaj   +1 more source

APOBEC3 activity and DNA polymerase‐ε deficiency are associated with distinct IDH1 R132 hotspot mutations

open access: yesMolecular Oncology, EarlyView.
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler   +3 more
wiley   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy